Back to Results

EFTA00075355.pdf

Source: DOJ_DS9  •  Size: 77.0 KB  •  OCR Confidence: 85.0%
View Original Image

Extracted Text (OCR)

FD-302 (Rev. 5-8-10) -1 of 2- FEDERAL BUREAU OF INVESTIGATION OFFICIAL RECORD Date of entry 09/05/2019 DR. KARI SCHLESSINGER, date of birth (DOB) , was interviewed at 1 Saint Andrews Plaza, New York, NY, 10007 (US Attorney's Office, Southern District of New York). Present at the interview was Office of the Inspector General (OIG) Special Agent (SA) , Assistant U.S. Attorney (AUSA) , and FBI SA . After being advised of the identity of the interviewing Agents and the nature of the interview, DR. SCHLESSINGER provided the following statement: DR. SCHLESSINGER has a PhD Psychology DR. SCHLESSINGER interned at in Metropolitan Detention Center in 2004. DR. SCHLESSINGER started working at Metropolitan Detention Center in 2005. DR. SCHLESSINGER transferred to Metropolitan Correctional Center in 2009. DR. SCHLESSINGER conducts Forensic Psychological Evaluations of inmates for the Bureau of Prisons. DR. SCHLESSINGER conducted an intake interview of EPSTEIN on July 8. 2019. During the interview, EPSTEIN denied any mental health history, suicide history, and substance abuse history. EPSTEIN stated, although he was in the "shoe", he was doing fine. (A copy of DR. SCHLESSINGER's July, 8, 2019, intake screening of EPSTEIN will be maintained in a IA ssociated with this serial). On August 9, 2019 at approximately 1:00pm, DR. SCHLESSINGER, acting for DR. MILLER, was present during a meeting regarding EPSTIEN. During the meeting, EPSTEIN's attorney was opposed EPSTEIN having a cell mate. During the meeting, ADAM JOHNSON and DR. SCHLESSINGER explained to EPSTEIN's attorney, that because EPSTEIN was in the "shoe", and he was a sex offender, Investigation on 08/30/2019 at NewYork, New York, United States (In Person) File# 90A-NY-3151227 Date drafted 09/05/2019 by This document contains neither recommendations nor conclusions of the FBI. It is the of the FBI and is loaned to your agency; it and its contents arc nor to be distributed outside your agency. EFTA00075355 FD-302a (Rev. 5-8-10) 90A-NY-3151227 Comthwdion of FD-302 of (U) Interview of DR. KARI SCHLESSINGER a 08/30/2019 ,page 2 of 2 EPSTEIN needed a cell mate. EPSTIEN's cell mate being released was never brought up that August 9, 2019 meeting. EFTA00075356

Document Preview

EFTA00075355.pdf

Click to view full size

Document Details

Filename EFTA00075355.pdf
File Size 77.0 KB
OCR Confidence 85.0%
Has Readable Text Yes
Text Length 2,282 characters
Indexed 2026-02-11T10:26:35.243976
Ask the Files